Wednesday, February 27, 2019

technology

Crispr Therapeutics and partner Vertex Pharmaceuticals said on Monday morning that the first patient in a trial using CTX001 received the one-time medicine.

from RSS Feeds | SCIENCE - RSS Feed - NDTV Gadgets360.com https://ift.tt/2XjoJ5n
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)